EU Council Resists Parliament Pressure To Pick Up The Pace On Reforms
This article was originally published in The Gray Sheet
Executive Summary
The body representing European Union country heads of state continues to lag well behind the European Parliament progress on comprehensive device and diagnostic regulatory reforms, and is resistant to nudges to speed things up.
You may also be interested in...
EU Accelerates Medtech Regulatory Reform Process
Recent votes suggest a possible acceleration in the negotiation process on European reforms to device and diagnostic regulatory oversight on the continent.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.